Initial commercial availability begins through an Early Experience Program with Penn Highlands Healthcare and Allegheny ...

Nordic Capital's investment in Evosep is based on its long-standing commitment to healthcare and diagnostics with deep expertise across biopharma, medtech and diagnostic technology, including ...

From decoding the diversity of brain cells to probing pollinators, Prof. Leonard Foster explores how proteomics can help ...

Proteomics International Laboratories Ltd. ( ($AU:PIQ) ) has issued an announcement. Proteomics International Laboratories Ltd announced its ...

This article highlights key preanalytical factors, including blood collection techniques, anticoagulant choice, ...

Initial commercial availability begins through an Early Experience Program with Penn Highlands Healthcare and Allegheny Health Network – SAN ...

Proteomics International has filled its pockets with $2.2 million in cash from a government R&D rebate to fuel its medical ...

Evosep, a global leader in proteomics solutions, is proud to announce a new initiative at HUPO 2025 aimed at solving one of ...

Nordic Capital has agreed to buy a majority stake in Evosep, a provider of sample preparation and separation software for LC-MS-based proteomics.

Perseus Proteomics, Inc. ( ($JP:4882) ) has shared an announcement. Perseus Proteomics, Inc. has announced an extension of the Phase I/II clinical ...

Personalized medicine promises to significantly improve patient outcomes, but achieving this requires a deep understanding of ...

Breast cancer is a highly heterogeneous malignancy among women worldwide. Traditional prognostic models relying solely on clinicopathological features offer limited predictive accuracy and lack ...